Hugo Solvet
Stock Analyst at Exane BNP Paribas
(1.10)
# 3,625
Out of 4,417 analysts
15
Total ratings
63.6%
Success rate
-4.3%
Average return
Main Sectors:
Stocks Rated by Hugo Solvet
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EPA: BIM bioMérieux S.A. | Downgraded: Hold | €100.00 | $68.10 | +46.84% | 1 | Jan 28, 2026 | |
| BIT: DIA DiaSorin S.p.A. | Upgraded: Hold | n/a | $66.44 | - | 2 | Jan 28, 2026 | |
| SWX: SOON Sonova Holding AG | Maintained: Sell | CHF 215.00 → CHF 195.00 | $193.40 | +0.83% | 3 | Oct 20, 2025 | |
| WILLF Demant A/S | Upgraded: Buy | $27 → $48 | $35.45 | n/a | 2 | Jun 11, 2025 | |
| AMS: PHIA Koninklijke Philips N.V. | Upgraded: Buy | €23.21 → €29.00 | $23.21 | n/a | 3 | Feb 25, 2025 | |
| ETR: SHL Siemens Healthineers AG | Upgraded: Buy | €63.00 | $35.30 | n/a | 1 | Feb 7, 2024 | |
| RGEN Repligen | Initiated Coverage: Buy | $330 | $131.69 | n/a | 1 | Oct 14, 2021 | |
| ETR: FME Fresenius Medical Care AG | Downgraded: Hold | €65.00 | $41.03 | n/a | 1 | Feb 4, 2021 | |
| QGEN Qiagen | Upgraded: Buy | $58 | $37.22 | n/a | 1 | Aug 14, 2020 |
bioMérieux S.A.
Jan 28, 2026
Downgraded: Hold
Price Target: €100.00
Current: $68.10
Upside: +46.84%
DiaSorin S.p.A.
Jan 28, 2026
Upgraded: Hold
Price Target: n/a
Current: $66.44
Upside: -
Sonova Holding AG
Oct 20, 2025
Maintained: Sell
Price Target: CHF 215.00 → CHF 195.00
Current: $193.40
Upside: +0.83%
Demant A/S
Jun 11, 2025
Upgraded: Buy
Price Target: $27 → $48
Current: $35.45
Upside: n/a
Koninklijke Philips N.V.
Feb 25, 2025
Upgraded: Buy
Price Target: €23.21 → €29.00
Current: $23.21
Upside: n/a
Siemens Healthineers AG
Feb 7, 2024
Upgraded: Buy
Price Target: €63.00
Current: $35.30
Upside: n/a
Repligen
Oct 14, 2021
Initiated Coverage: Buy
Price Target: $330
Current: $131.69
Upside: n/a
Fresenius Medical Care AG
Feb 4, 2021
Downgraded: Hold
Price Target: €65.00
Current: $41.03
Upside: n/a
Qiagen
Aug 14, 2020
Upgraded: Buy
Price Target: $58
Current: $37.22
Upside: n/a